Jim Simons Astrazeneca PLC Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Astrazeneca PLC stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,303,773 shares of AZN stock, worth $109 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,303,773

Previous 299,200 335.75%

Holding current value

$109 Million

Previous $22 Million 314.29%

% of portfolio

0.13%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$64.87 - $75.0 $65.2 Million - $75.3 Million	1,004,573 Added 335.75%	1,303,773 $91.1 Million
Q1 2025 May 14, 2025	BUY	$65.37 - $77.96 $18.2 Million - $21.7 Million	278,830 Added 1368.83%	299,200 $22 Million
Q4 2024 Feb 13, 2025	SELL	$63.2 - $79.58 $18 Million - $22.6 Million	-284,538 Reduced 93.32%	20,370 $1.33 Million
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $19 Million - $21.7 Million	247,408 Added 430.27%	304,908 $23.8 Million
Q2 2024 Aug 09, 2024	SELL	$66.81 - $80.83 $42.3 Million - $51.1 Million	-632,444 Reduced 91.67%	57,500 $4.48 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $1.43 Million - $1.63 Million	-23,500 Reduced 3.29%	689,944 $46.7 Million
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $63.8 Million - $71.4 Million	-1,030,233 Reduced 59.08%	713,444 $48.1 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $32.5 Million - $36 Million	501,714 Added 40.4%	1,743,677 $118 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $67.7 Million - $73.4 Million	-968,039 Reduced 43.8%	1,241,963 $88.9 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $88.9 Million - $101 Million	-1,407,844 Reduced 38.91%	2,210,002 $153 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $118 Million - $154 Million	-2,181,726 Reduced 37.62%	3,617,846 $245 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $3.15 Million - $8.08 Million	-59,500 Reduced 1.02%	5,799,572 $318 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $76.9 Million - $92.3 Million	1,297,244 Added 28.44%	5,859,072 $387 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $70 Million - $84.4 Million	-1,257,000 Reduced 21.6%	4,561,828 $303 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $57.6 Million - $68 Million	-1,065,548 Reduced 15.48%	5,818,828 $339 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $371 Million - $406 Million	6,682,676 Added 3313.18%	6,884,376 $413 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $8.85 Million - $11 Million	182,800 Added 967.2%	201,700 $12.1 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $16.4 Million - $18.9 Million	-347,200 Reduced 94.84%	18,900 $940,000
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $13.8 Million - $16.5 Million	-284,189 Reduced 43.7%	366,100 $18.3 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $145 Million - $167 Million	-2,739,666 Reduced 80.82%	650,289 $35.6 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $17 Million - $21.8 Million	-394,951 Reduced 10.43%	3,389,955 $179 Million
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $111 Million - $150 Million	2,925,406 Added 340.36%	3,784,906 $169 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $30.3 Million - $36 Million	712,900 Added 486.29%	859,500 $42.9 Million
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $50.3 Million - $57 Million	-1,254,037 Reduced 89.53%	146,600 $6.53 Million
Q2 2019 Aug 12, 2019	SELL	$37.28 - $41.68 $16.5 Million - $18.5 Million	-443,663 Reduced 24.06%	1,400,637 $57.8 Million
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $65.5 Million - $79.3 Million	1,844,300 New	1,844,300 $74.6 Million

Others Institutions Holding AZN

# of Institutions

1,421

Shares Held

498M

Call Options Held

7.11M

Put Options Held

2.57M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $260B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account